BJP leader declares Rs 10 lakh reward for beheading Moulvi

Bengaluru, Jun 30: In an attempt to tackle unemployment amidst covid-19 crisis, the Karnataka state government has launched a job portal connecting employers and job seekers.

The portal, 'Skill connect' ( https://skillconnect.kaushalkar.com/ ) provides region-wise and sector-wise job listings. An interested candidate can register on the portal and either apply for jobs or can also seek skill training. 

As on Monday, the portal has 25 registered companies with over 2000 jobs available in various sectors. 

The portal works more or less on similar lines as that of any private job portal, except that those posting jobs and candidates searching for employment will have to register with the Skill Development Department. 

Launching the portal on Monday, Chief Minister BS Yediyurappa hoped that the portal would provide an impetus to job creation, as well as the economic revival of the state. 

Deputy Chief Minister Dr. C.N. Ashwath Narayan who is also the skill development Minister added, "All these years, there was no information and communication between job seekers and recruiters. This portal will solve that problem."

Also, until now, there hasn't been comprehensive information either on those seeking jobs or those looking for employees. The skill development efforts have not been in sync with the market. All these issues would be addressed by the portal, he said. 

According to Karnataka Skill Development Authority Managing Director Ashwin Gowda, the portal has already seen a response with about 68 applicants in just a day. 

Officials said even the organisations will have to register with the government while providing all documents concerned. The government aims to avoid any fake job advertisements through this. "We will also enable virtual interviews between the candidate and the employer," sources in the department told DH. 

Recently, the government had also launched a portal exclusively for migrants who had returned to Karnataka from other places. This was meant to work as a skill registry.

However, the portal that was launched on Monday, went a step ahead by connecting both the prospective employers and employees, according to officials in the department.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.